Early hypertension and neutropenia are predictors of treatment efficacy in metastatic colorectal cancer patients administered FOLFIRI and vascular endothelial growth factor inhibitors as second‐line chemotherapy

Abstract Background Three vascular endothelial growth factor (VEGF) inhibitors, Bevacizumab (BEV), ramucirumab (RAM), and aflibercept (AFL), are widely used for metastatic colorectal cancer (mCRC) patients who are treated with second‐line chemotherapy. The difference in outcome between the three dru...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Hiroki Osumi, Eiji Shinozaki, Akira Ooki, Takeru Wakatsuki, Daisaku Kamiimabeppu, Taro Sato, Izuma Nakayama, Mariko Ogura, Daisuke Takahari, Keisho Chin, Kensei Yamaguchi
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2021-01-01
Ráidu:	Cancer Medicine
Fáttát:	angiogenesis inhibitors colorectal cancer drug response biomarkers vascular endothelial growth factors
Liŋkkat:	https://doi.org/10.1002/cam4.3638
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!